Lawrence, KS, United States of America

Emily Reiff

This inventor holds 3 USPTO granted patents. Top assignee: University of Kansas. Active years: 2001-2003.


% Patents Active = 33.3

Average Co-Inventor Count = 4.6

ph-index = 3

Forward Citations = 66(Granted Patents)


Company Filing History:


Years Active: 2001-2003

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Emily Reiff: Innovator in Epothilone Synthesis

Introduction

Emily Reiff is a prominent inventor based in Lawrence, KS (US). She has made significant contributions to the field of chemistry, particularly in the synthesis of epothilones. With a total of 3 patents to her name, her work has implications for the pharmaceutical industry.

Latest Patents

Emily's latest patents focus on the synthesis of epothilones. One of her notable patents provides commercially feasible methods for synthesizing various epothilone precursors needed for the preparation of final epothilones. This includes techniques for the synthesis of epothilone segment A and C precursors. Segment C precursors are prepared using starting nitriles, which can alternately be oxidized to ketones and converted, or reacted to form the diol with subsequent conversion to the segment. Segment A precursors are prepared by reacting a starting enone with a chiral catalyst to give an intermediate alcohol in high enantomeric excess, followed by conversion of the alcohol to the desired Segment A precursor.

Career Highlights

Emily Reiff is affiliated with the University of Kansas, where she conducts her research and development. Her work has garnered attention for its innovative approaches to complex chemical synthesis.

Collaborations

Some of her notable coworkers include Sajiv K Nair and Gunda I Georg. Their collaborative efforts contribute to the advancement of research in the field of epothilone synthesis.

Conclusion

Emily Reiff is a key figure in the innovation of epothilone synthesis, with her patents paving the way for advancements in pharmaceutical applications. Her contributions continue to impact the scientific community positively.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…